Skip to content

Ultragenyx Pharmaceutical

US · RARE #3012 by market cap Listed 1970
16.48 -0.74 -4.30%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:31

About Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Founded
2010
CEO
Dr. Emil D. Kakkis, M.D.,PhD
Employees
1,371
Headquarters
Novato, California, United States of America
Fiscal year end
12-31
Website
ultragenyx.com

Company profile

Exchange
US
Symbol
RARE
Market-cap rank
#3012
Listing date
1970-01-01
Market cap
1.68B
Float cap
1.38B
Shares out
101.92M
Float shares
83.54M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:31:44 · For reference only, not investment advice and not tailored to your situation.

Ultragenyx Pharmaceutical discussion 0 comments

Add a comment